Stockscreener 앱 받기
3.18
0.00%
0.00
Macrogenics Inc 주식(MGNX)의 최신 뉴스
MacroGenics, Inc. (NASDAQ:MGNX) Shares Acquired by Fmr LLC - Defense World
MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Victoria Advocate
Faruqi & Faruqi Reminds MacroGenics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 24, 2024MGNX - The Eastern Progress Online
MacroGenics, Inc. (NASDAQ:MGNX) Shares Sold by Charles Schwab Investment Management Inc. - Defense World
Analysts Set MacroGenics, Inc. (NASDAQ:MGNX) PT at $7.63 - MarketBeat
MacroGenics' SWOT analysis: oncology firm faces pipeline challenges, stock outlook mixed - Investing.com Australia
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics - The Eastern Progress Online
Pharma Co. Brass Face Investor Suit Over Drug Trial Probe - Law360
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against MacroGenics, Inc.MGNX - The Eastern Progress Online
MacroGenics, Inc. Class Action: The Gross Law Firm Reminds MacroGenics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 24, 2024MGNX - The Eastern Progress Online
Investors in MacroGenics, Inc. Should Contact Levi & Korsinsky Before September 24, 2024 to Discuss Your RightsMGNX - The Eastern Progress Online
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics - The Eastern Progress Online
MGNX ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
MacroGenics, Inc. Investors Reminder: Kessler Topaz Meltzer & Check, LLP Reminds MacroGenics, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit - The Eastern Progress Online
Shareholders that lost money on MacroGenics, Inc.(MGNX) Urged to Join Class ActionContact The Gross Law Firm to Learn More - The Eastern Progress Online
Jacobs Levy Equity Management Inc. Purchases 147,438 Shares of MacroGenics, Inc. (NASDAQ:MGNX) - MarketBeat
MGNX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MacroGenics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - The Eastern Progress Online
Investors who lost money on MacroGenics, Inc.(MGNX) should contact The Gross Law Firm about pending Class ActionMGNX - The Eastern Progress Online
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics - The Eastern Progress Online
MGNX Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against MacroGenics, Inc. - The Eastern Progress Online
MacroGenics: A Productive Biotech With Growing PotentialStill Not A Buy - Seeking Alpha
MacroGenics to Participate in Upcoming Investor Conference - The Manila Times
MacroGenics CEO to Present at Evercore HealthCONx Conference, Spotlights Cancer Therapeutics - StockTitan
MGNX (Macrogenics) 3-Year Revenue Growth Rate : -20.90% (As of Sep. 2024) - GuruFocus.com
MGNX (Macrogenics) Owner Earnings per Share (TTM) : -1.32 (As of Sep. 2024) - GuruFocus.com
MGNX (Macrogenics) Growth Rank : 1 (As of Nov. 28, 2024) - GuruFocus.com
2.88%
2.65%
자본화:
|
볼륨(24시간):